Skip to main content
. 2014 Sep 15;7(9):2966–2975.

Table 2.

Outcome variables in randomized controlled trials

Author (published year) Pain Score, Mean ± SD (numbers) side effect control number/total numberTAP block number/total number

2 h 6 h 24 h

control TAP control TAP control TAP
Walter Catherine J (2013) at rest 3.5 ± 2.2 (32) 4 ± 3.1 (31) 3.6 ± 2.6 (31) 2.9 ± 2.8 (30) 2.8 ± 2.3 (33) 3.0 ± 2.3 (33) nausea or vomiting placebo: 1/34 TAP block: 9/33
on movement 4.6 ± 2.5 (32) 4.4 ± 3.0 (31) 4.1 ± 2.9 (31) 3.7 ± 2.8 (30) 3.6 ± 2.7 (33) 3.7 ± 2.4 (33) NR
Sinha A (2013) at rest and on movement 1.3 ± 1.5 (50) 1.5 ± 1.8 (50) 0.5 ± 0.6 (50) 1.3 ± 1.5 (50) 0.5 ± 0.6 (50) 0.5 ± 0.6 (50) required BIPAP support control group control: 4/31 TAP: 0/31
Parikh BK (2013) at rest 2.4 ± 1.5 (31) 1.0 ± 0.7 (31) 3.2 ± 1.09 (31) 1.8 ± 1.05 (31) 2.3 ± 0.8 (31) 1.9 ± 0.8 (31) NR
on movement 4.03 ± 1.6 (31) 2.1 ± 0.6 (31) 4.7 ± 1.4 (31) 3.2 ± 1.4 (31) 3.8 ± 1.1 (31) 3.43 ± 0.9 (31)
Albrecht E (2013) at rest and on movement 4.4 ± 0.8 (31) 4.8 ± 0.7 (31) 3.5 ± 0.8 (31) 4.1 ± 0.7 (31) nausea or vomiting control: 4/30 TAP: 8/27
Petersen PL (2012) at rest 3.7 ± 1.9 (37) 3.1 ± 1.8 (37) 2.1 ± 1.4 (37) 1.9 ± 1.5 (37) 1.6 ± 1.6 (37) 1.5 ± 1.2 (37) nausea or vomiting control: 13/37 TAP: 8/37
on movement 5.1 ± 2.4 (37) 2.9 ± 2.0 (37) 3.5 ± 1.9 (37) 2.6 ± 1.9 (37) 2.5 ± 2.0 (37) 2.4 ± 1.6 (37) NR
Ortiz J (2012) at rest and on movement 2.17 ± 0.35 (35) 3.0 ± 0.43 (39) 3.53 ± 0.47 (35) 3.05 ± 0.53 (39) NR NR nausea control: 13/35 TAP: 17/39
Kane SM (2012) at rest and on movement 2.4 ± 6.6 (28) 3.0 ± 2.6 (28) NR NR 3.0 ± 2.6 (28) 2.4 ± 2.1 (28) NR
Hosgood SA (2012) NR NR NR NR NR NR NR Nausea and vomiting control: 9/22 TAP: 10/24
Ra Yoon Suk (2010) at rest and on movement 6.9 ± 1.57 (18) 2.6 ± 1.46 (18) 6.1 ± 1.98 (18) 1.9v1.43 (18) 4.4 ± 1.68 (18) 1.3 ± 0.97 (18) NR

TAP, transversus abdominal block; NR, no reported.